Previous Article | Next Article 
Journal of Virology, November 1999, p. 9337-9347, Vol. 73, No. 11
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
The Mode and Duration of Anti-CD28 Costimulation Determine
Resistance to Infection by Macrophage-Tropic Strains of Human
Immunodeficiency Virus Type 1 In Vitro
Jennifer R.
Creson,
Andy A.
Lin,
Qun
Li,
David F.
Broad,
Margo R.
Roberts,
and
Stephen J.
Anderson*
Cell Genesys, Inc., Foster City, California
94404
Received 16 December 1998/Accepted 6 August 1999
 |
ABSTRACT |
We have investigated the ability of anti-CD28 antibody
costimulation to induce resistance to macrophage (M)-tropic strains of
human immunodeficiency virus type 1 (HIV-1) in vitro. Our results confirm the observations of Levine et al. (15) that
stimulation of CD4 T cells with anti-CD3/anti-CD28 antibodies
coimmobilized on magnetic beads renders the cells resistant to
infection by M-tropic strains of HIV-1. The resistance was strongest
when the beads were left in the cultures throughout the experiment. In contrast, stimulation of CD4 T cells with the same antibodies immobilized on the surface of plastic culture dishes failed to induce
resistance and resulted in high levels of p24 production. This was true
even if the cells were passaged continuously on freshly coated plates.
If the beads were removed after initial stimulation, p24 production
increased over time and produced a result intermediate to the other
forms of stimulation. For beads-in, beads-out, and one-time plate
stimulated cultures, resistance to infection correlated with
down-regulation of CCR5 expression at the cell surface and with
increased production of
-chemokines. However, cultures of CD4 T
cells continuously passaged on anti-CD3/anti-CD28-coated plates
produced large amounts of p24 despite decreased levels of CCR5
expression and increasing production of
-chemokines. Expression of
the T-cell activation markers CD25 and CD69 and production of gamma
interferon further supported the differences in plate versus bead
stimulation. Our results explain the apparent contradiction between the
ability of anti-CD28 antibody costimulation to induce resistance to HIV
infection when presented on magnetic beads and the increased ability to
recover virus from the cells of HIV-positive donors who are on highly
active antiretroviral therapy when cells are stimulated by
anti-CD3/anti-CD28 immobilized on plastic dishes.
 |
INTRODUCTION |
The inability to grow autologous T
cells ex vivo, in particular CD4 T cells, from human immunodeficiency
virus (HIV)-positive donors has been a major stumbling block for the
development of T-cell replacement therapies for AIDS. Recently, Levine
et al. developed a method for expanding CD4 T cells from HIV-positive donors in vitro in the absence of antiretroviral drugs with minimal viral replication (15, 16). Their method uses stimulation of
highly purified CD4 T cells with anti-CD3 and anti-CD28 antibodies coimmobilized on magnetic beads. They have further shown that costimulation of CD4 T cells by anti-CD28-coated beads renders the
cells resistant to infection by macrophage (M)-tropic strains of HIV
type 1 (HIV-1) in vitro (5, 15, 20). HIV production is
negligible after the first 2 weeks of culture in the absence of
antiviral drugs, and proviral DNA is nearly undetectable. The mechanism
by which CD28 costimulation induces resistance appears to have two
components. The first is by inducing the production of high levels of
-chemokines (MIP-1
, MIP-1
, RANTES) which can block access to
CCR5, the coreceptor for M-tropic strains of HIV-1 (5, 20).
This component is independent of CD28 and can be achieved by
costimulation with other T-cell surface receptors such as CD2, CD4,
CD5, or CD8 (20). The second component, which is dependent
on costimulation by CD28, is the down-regulation of CCR5 expression at
the RNA level (20).
In contrast, other groups have reported that costimulation with
anti-CD3/anti-CD28 can result in increased virus production (2,
21, 24). In these reports, costimulation with anti-CD28 by
antibodies immobilized on plastic dishes or provided by B7 expression
on fixed antigen-presenting cells resulted in increased p24 production
by primary CD4 T cells compared to that resulting from stimulation by
phytohemagglutinin or anti-CD3 alone. However, both groups used
T-tropic viruses, which were not inhibited by CD3/CD28 bead stimulation
in the studies of Levine et al. (15). Recently,
costimulation of patient T cells by anti-CD3 and anti-CD28 antibodies
immobilized on plastic dishes was demonstrated to be a highly sensitive
technique for recovery of HIV from the cells of patients on highly
active antiretroviral therapy with no detectable virus load
(27). This observation is particularly significant since
most primary isolates of HIV-1 are M-tropic CCR5-dependent viruses
(7, 18, 19). Together these results show that costimulation with anti-CD3/anti-CD28, under certain circumstances, can result in
enhanced replication of M-tropic as well as T-tropic strains of HIV.
To more closely examine the issue of resistance to HIV infection, we
stimulated highly enriched populations of primary human CD4 T cells
with anti-CD3/anti-CD28 antibodies immobilized on magnetic beads or on
the surface of plastic culture dishes. Our experiments confirmed that
costimulation with anti-CD3/anti-CD28 beads reduces p24 production but
that the mode and duration of exposure to anti-CD28 have a significant
impact on the extent of resistance to M-tropic strains of HIV-1 in
vitro. Whereas stimulation of CD4 T cells with anti-CD3/anti-CD28 beads
almost completely inhibited replication of HIV as measured by p24
production, stimulation by antibodies immobilized on plastic dishes
resulted in high levels of p24 production. This was true even with
continuous passage of cells on freshly coated plates. Increased
production of
-chemokines and decreased CCR5 coreceptor expression
correlated with the induction of resistance to HIV infection denoted by
decreased p24 production. The exception was continuous plate
stimulation which led to high levels of p24 production despite
down-regulation of CCR5 and increased production of
-chemokines.
Anti-CD3/anti-CD28 bead stimulation further gave rise to increased
expression of the T-cell activation markers CD25 and CD69 and also with
increased production of gamma interferon (IFN-
) in comparison to
that resulting from stimulation with antibodies immobilized on plates.
These results suggest that the strength and duration of the activation
signal(s) play a role in the ability of CD28 costimulation to induce
resistance and further explain how CD28 costimulation can induce
resistance to HIV infection under certain conditions and result in
increased virus production in others.
 |
MATERIALS AND METHODS |
Normal donor cells and culture conditions.
Fresh normal
donor peripheral blood mononuclear cells isolated by Ficoll-Hypaque
centrifugation were enriched for CD4+ T cells by depletion
of CD8+ and CD14+ cells by using
antibody-coated magnetic beads (Dynabeads M-450; Dynal, Lake Success,
N.Y.) in accordance with the manufacturer's instructions. The
resulting T-cell population typically contained 60 to 85%
CD4+ T cells, with <10% CD8+ and the
remainder being CD4
CD8
. All cells were
diluted to a concentration of 106/ml by using fresh AR
medium (a 1:1 mixture of AIM V medium [GIBCO, Grand Island, N.Y.]
supplemented with 4 mM L-glutamine and RPMI 1640 medium
[JRH Biosciences, Lenexa, Kans.] supplemented with 10%
heat-inactivated fetal bovine serum [HyClone Laboratories, Inc.,
Logan, Utah], 4 mM L-glutamine, 100 U of penicillin per ml, 100 µg of streptomycin per ml, and 10 mM HEPES, giving a final concentration of 5% fetal bovine serum). Cultures were split and fed
with fresh AR medium supplemented with 100 IU of recombinant human
interleukin-2 (IL-2) (Proleukin; Chiron Therapeutics, Emeryville, Calif.) on days 3, 5, 7, 10, and 13 poststimulation to maintain a
concentration of 106 cells/ml.
Stimulation.
CD4-enriched T-cell populations were stimulated
with anti-CD3 (OKT3; Ortho Diagnostics, Raritan, N.J.) and anti-CD28
(Leu-28; Becton Dickinson Immunocytometry Systems, San Jose, Calif.)
monoclonal antibodies either directly coated on plastic tissue culture
plates or immobilized on sheep anti-mouse immunoglobulin G-coated
magnetic beads (Dynabeads M-450; Dynal) with a concentration of 150 fg of each antibody per bead (17). In a typical experiment, 500 ng of each antibody per ml was used to coat plates while bead stimulation was performed with a bead/cell ratio of 3:1. On day 3 poststimulation, T cells were removed from the coated plates while
bead-stimulated cells were split into two cultures; beads were either
removed (beads-out) or left in the culture for the duration of the
experiment (beads-in). For continuous plate stimulation, the day 3 plate-stimulated culture was split into two subcultures, one of which
was transferred to a fresh plate coated with anti-CD3 and anti-CD28
antibodies and continuously passaged on fresh anti-CD3/anti-CD28-coated plates (continuous plate) and the other of which was maintained by
using uncoated plates (one-time plate).
HIV infections.
On days 3 and 7 poststimulation, cells were
infected with the M-tropic strains of HIV-1, JRCSF or SF162, by
resuspending 106 cells directly in supernatant containing
approximately 50 ng of p24 for 4 h at 37°C, after which excess
virus was removed by centrifugation and 106 infected cells
were cultured in 2 ml of AR medium with 100 IU of IL-2 per ml. To
minimize the potential stearic inhibition of infection by beads bound
to the cells in bead-stimulated cultures, the clumps of beads and cells
were disrupted as much as possible by vigorous pipetting during
resuspension with the virus-containing supernatant. This procedure
results in a near-single-cell suspension, with none to a few beads
bound to each cell as observed microscopically. Aliquots of supernatant
from the infected cultures were removed on days 3 and 7 postinfection
and analyzed for p24 by enzyme-linked immunosorbent assay (ELISA) (p24
ELISA kit; DuPont-NEN, Boston, Mass.). Where indicated, infected
plate-stimulated or beads-out cells were resuspended in 100%
conditioned medium (CM) from a noninfected beads-in culture harvested
the same day as the day of infection and spiked with 100 IU of IL-2 per ml.
Surface antigen expression and cytokine production.
The
composition of the enriched cell populations was assessed by directly
staining the cells with fluorochrome-conjugated anti-CD3, -CD4, -CD8,
and -CD14 antibodies (Dako, Carpinteria, Calif., or Coulter/Immunotech,
Miami, Fla.) by using standard methods and analyzed by flow cytometry
with a Becton-Dickinson FACScan instrument and CellQuest analysis
software. At indicated times poststimulation, noninfected cells were
surface stained for the expression of the coreceptor CCR5 by using a
phycoerythrin-conjugated monoclonal antibody to CCR5 (clone no. 2D7;
Pharmingen, San Diego, Calif.) and for the T-cell activation markers
CD25 and CD69 (anti-IL-2 receptor-fluorescein isothiocyanate-FITC and
Leu-23-fluorescein isothiocyanate, respectively; Becton Dickinson
Immunocytometry Systems, San Jose, Calif.). For
-chemokine and
cytokine production, aliquots of media were removed at the indicated
times poststimulation and analyzed for the presence of RANTES,
MIP-1
, MIP-1
, and IFN-
by ELISA (Quantikine kits; R&D Systems,
Minneapolis, Minn.).
 |
RESULTS |
Resistance to HIV infection is induced by bead stimulation but not
by plate-bound anti-CD3/anti-CD28.
To determine if alternative
forms of anti-CD3/anti-CD28 antibody costimulation had equal abilities
to render cultured T cells resistant to infection with M-tropic strains
of HIV-1, we stimulated enriched CD4 T cells (60 to 85%
CD4+) with antibodies bound to magnetic beads or
immobilized on plastic culture dishes. Initially, three culture
conditions were compared: (i) antibody-coated magnetic beads left in
the cultures throughout the experiment (beads in) analogous to the
method of Levine et al. (15, 16); (ii) beads removed on day
3 poststimulation prior to infection (beads out); and (iii) antibodies
immobilized on plastic culture plates with cells removed from the
plates on day 3 poststimulation, prior to infection (plate). On day 3 or day 7 poststimulation, the T cells were infected with the M-tropic strains of HIV-1, JRCSF or SF162, as described in Materials and Methods. HIV replication in the cultures was measured on day 3 and day
7 postinfection by p24 ELISA. In cultures of CD4 T cells stimulated
with anti-CD3/anti-CD28 beads, little or no p24 was produced in the 7 days following infection with either of the M-tropic virus strains
(Table 1). This was true if cells were infected on either day 3 or day 7 poststimulation but only if the beads
were left in the culture. In contrast, cultures of cells stimulated by
CD3/CD28 bound to plastic dishes produced high levels of p24 following
infection. Production of p24 correlated directly with the growth rate
of the cells, which varied from donor to donor. Supernatant p24 was
detectable by day 3 postinfection and increased as much as 10-fold by
day 7 postinfection. However, in some experiments, p24 levels were
lower on day 7 postinfection. This is most likely due to the cytopathic
effects of high amounts of virus replication at early times
postinfection. In the majority of experiments, p24 production was lower
in beads-out cultures than in plate-stimulated cultures following
infection on day 3 poststimulation (Table 1). This was true for both
JRCSF and SF162 and was more pronounced on day 3 postinfection than on
day 7 postinfection. For infections on day 7 poststimulation, p24
production in beads-out cultures is much more vigorous and often higher
than in plate-stimulated cultures. Again, this reflects a higher rate
of cell growth in the beads-out cultures and also the lower levels of
virus replication at early times postinfection. These results suggest
that there is some resistance to infection in beads-out cultures when
infections are performed immediately following bead removal, but the
effect is lost over time. Thus CD3/CD28 costimulation has completely opposite effects on the replication of M-tropic strains of HIV-1 depending on how the antibodies are immobilized and how long the cells
are exposed to the stimulation. The inability of these viruses to
propagate in cultures of bead-stimulated cells so long as the beads
remain present suggests that they are resistant to further infection.
Furthermore, the observation that beads-in stimulated cells infected on
day 7 poststimulation, when the bead/cell ratio has become less than
1:1 (by dilution), still fail to generate significant virus replication
argues against stearic inhibition of infection by the beads.
Down-regulation of CCR5 surface expression correlates with
resistance induced by CD3/CD28 beads.
Since resistance to HIV
infection was reported to involve down-regulation of CCR5 mRNA
(5), we examined our cultures to see if the differences in
p24 production by cells stimulated by CD3/CD28 on beads or plates could
be attributed to differences in CCR5 expression on the cell surface.
Noninfected enriched CD4 T cells were stained for CCR5 expression and
analyzed by flow cytometry. CCR5 expression was analyzed in eight
donors over several independent experiments with similar results in
each case. Representative data is shown in Fig.
1. Initially, only a small percentage of resting CD4 cells had CCR5 expression detectable by
fluorescence-activated cell sorting (Fig. 1, day 0). Following bead
stimulation, CCR5 expression disappeared from the cell surface and was
not detectable for at least 13 days poststimulation so long as the
beads remained present in cultures. If the beads were removed on day 3 poststimulation, CCR5 expression gradually returned, reaching
detectable levels by day 7 to 10 poststimulation. In contrast, CCR5
expression was significantly increased after stimulation by antibodies
immobilized on plastic dishes, with the majority of the cells being
positive by day 13 poststimulation and some expressing relatively high levels of CCR5. Our results using fluorescence-activated cell sorting
to detect cell surface expression are consistent with the observations
of Carroll et al. (5) that CCR5 expression is down-regulated
by stimulation with anti-CD3/anti-CD28-coated beads but further show
that plate-immobilized antibody stimulation has the opposite effect,
significantly increasing expression of CCR5.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 1.
Surface expression of CCR5 increases over time in plate
and beads-out cultures but remains undetectable in the continuous
presence of CD3/CD28 beads. Noninfected CD4-enriched T cells (60 to
85% CD4+) stimulated with anti-CD3 and anti-CD28
antibodies immobilized on magnetic beads or on plastic tissue culture
plates as described in the legend for Table 1 were collected at various
times poststimulation, stained with anti-CCR5 phycoerythrin, and
analyzed by flow cytometry. The day 0 point shows CCR5 expression
before stimulation (dotted line, isotype control). Data are shown for
days 0, 3, 7, and 13 representing the beginning and end of the cultures
and the days on which infections were performed in Table 1.
|
|
Stimulation of
-chemokine production correlates with resistance
to HIV infection.
The presence of
-chemokines in the culture
supernatant of stimulated T cells could interfere with infection by
competing for binding to the chemokine receptors. This has been
reported as a mechanism for inhibiting HIV infection (1, 6, 8, 9,
23, 26, 28). Riley et al. (20) also reported that one
factor in the induction of HIV resistance induced by costimulation was
the induction of
-chemokine secretion, although this mechanism was
not dependent on CD28 per se. When we assayed our cultures for the
presence of the
-chemokines MIP-1
, MIP-1
, and RANTES, we found
that bead-stimulated cells produced high levels of all three chemokines
while plate-stimulated cells produced markedly lower levels of
-chemokines (Fig.
2A). The
differences in
-chemokine production were most pronounced at later
times poststimulation. In bead-stimulated cultures, the levels of all
three chemokines remained elevated for the entire culture period while
declining rapidly in plate-stimulated cultures. In cultures of cells
where the beads were removed on day 3 poststimulation, there was an initial burst of chemokine production which then rapidly declined following bead removal. A similar pattern of
-chemokine production was observed in five different donors. The latter observation indicates
that continuous presence of CD3/CD28 stimulation is necessary for
maintaining high levels of
-chemokine production.



View larger version (43K):
[in this window]
[in a new window]
|
FIG. 2.
-Chemokine production varies with the method of
CD3/CD28 stimulation. (A) Production of -chemokines by noninfected
cells. Aliquots of culture supernatants from noninfected CD4-enriched
primary T cells were collected on days 3, 5, 7, 10, and 13 poststimulation and assayed for the presence of RANTES, MIP-1 , and
MIP-1 by ELISA. Results of a representative experiment are shown. (B
and C) CM from beads-in cultures inhibits replication of M-tropic
viruses. Cultures were infected on day 3 or day 7 poststimulation with
50 ng of p24/106 cells of HIV-1 JRCSF (B) or SF162 (C),
washed, and resuspended in either fresh medium or 100% CM from the
beads-in culture collected on the same day poststimulation. All
cultures were supplemented with 100 IU of IL-2 per ml. Panel B shows
the inhibition of JRCSF replication in plate-stimulated cultures
following infection on day 3 or day 7 poststimulation. Panel C shows
inhibition of SF162 replication in plate-stimulated cultures following
infection on day 3 poststimulation.
|
|
To further demonstrate the importance of chemokines in inhibiting HIV
infection, we added CM collected from the bead-stimulated (beads-in)
cultures to cultures of cells where the beads had been removed or where
cells were stimulated by plate-bound antibodies. The CM was harvested
the same day poststimulation on which the infections were performed
(day 3 or day 7). Figure 2B shows that the presence of CM from the
beads-in cultures greatly inhibited p24 production in cultures of
plate-stimulated cells or cultures where the beads were removed, even
when added after the infection had occurred. Replication of both JRCSF
and SF162 (Fig. 2C) was inhibited in the presence of CM in independent
experiments with two different donors. This inhibition is presumably
because of competition for coreceptor binding, down-regulation of the
coreceptor from the surface as a result of chemokine binding, or both.
Together these data indicate that the availability of the HIV
coreceptor plays a critical role in the propagation of HIV infection in vitro.
Higher and prolonged expression of T-cell activation markers in
bead-stimulated cultures.
The data presented above indicate that
the duration of exposure to CD3/CD28 stimulation is important for
maintaining a state of resistance to HIV infection in vitro. The
observation that there are differences in CCR5 expression and
-chemokine production evident on day 3 poststimulation further
suggests that there may be some intrinsic differences in bead versus
plate stimulation. One possible explanation for the differences in the
effects of CD3/CD28 immobilized on magnetic beads versus those on
plastic dishes is that the quality or strength of the signal differs
between the two methods. We addressed this indirectly by looking at the expression of T-cell activation markers following stimulation by either
CD3/CD28 beads or plate-bound antibodies. CD69 is the earliest known
activation marker to appear on the cell surface following stimulation
(25). CD25, the IL-2 receptor
-chain, appears shortly
after CD69 and declines as cell proliferation decreases (4,
11). We compared CCR5, CD25, and CD69 expression levels in our
enriched CD4 T-cell populations (60 to 85% CD4+) following
various forms of CD3/CD28 stimulation. The data shown in Fig.
3 is from one of three different donors
where a direct comparison of all three markers was
performed. CCR5 expression remained absent from bead-stimulated cells
in the continuous presence of beads, gradually returned when beads were
removed, and was up-regulated in plate-stimulated cultures as described
above (Fig. 3A). Both CD69 and CD25 expression levels were induced
following stimulation with anti-CD3/anti-CD28 regardless of which
method was used, although the induction was more profound on day 3 following bead stimulation (Fig. 3B and C). By day 5 poststimulation,
CD69 levels had returned to baseline in the plate-stimulated cultures and in cultures where the beads were removed. In cultures where beads
remained present (beads-in), CD69 expression remained elevated for at
least 13 days poststimulation. CD25 expression remained elevated
throughout the culture period when the beads were left in. Expression
gradually returned to baseline levels in plate-stimulated cultures and
in cultures where the beads were removed but remained elevated longer
in the beads-out cultures. We also looked at production of IFN-
as
an indicator of the level of T-cell activation in the same three
donors. Representative results from one donor are shown in Fig.
4. The levels of IFN-
produced as a
result of various forms of CD3/CD28 stimulation followed the same
pattern as the production of
-chemokines. The production of IFN-
was higher and lasted longer in bead-stimulated cultures where the
beads were left in and dropped steadily in cultures of plate-stimulated cells or cultures where the beads were removed, although the drop seemed more precipitous in the plate-stimulated cultures. A similar pattern was observed in the other two donors. These data indicate that
prolonged expression of T-cell activation markers correlates with a
decrease in CCR5 expression and increased production of
-chemokines
and IFN-
and further demonstrates that duration of exposure to
anti-CD3/anti-CD28 stimulation is important for maintaining a high
level of T-cell activation. The differences in CD25 and CD69 expression
on day 3 poststimulation suggest that immobilizing the antibodies on
beads provides a more potent signal than the same antibodies
immobilized on the surface of a culture dish.



View larger version (64K):
[in this window]
[in a new window]
|
FIG. 3.
Increased expression of CD69 and CD25 and decreased
expression of CCR5 in bead-stimulated cells. Noninfected CD4-enriched T
cells (60 to 85% CD4+) were stimulated as indicated and
stained for the expression of CCR5, CD25, and CD69 at various times
poststimulation as described in the legend to Fig. 1. (A) CCR5
expression; (B) CD25 expression; (C) CD69 expression.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 4.
Production of IFN- correlates with production of
-chemokines in anti-CD3/anti-CD28-stimulated cultures. Aliquots of
culture supernatants from noninfected CD4-enriched T cells were
collected on days 3, 5, 7, 10, and 13 poststimulation by the indicated
methods and assayed for the presence of IFN- as well as RANTES,
MIP-1 , and MIP-1 by ELISA. Results of a representative experiment
are shown.
|
|
Continuous passage on anti-CD3/anti-CD28-coated plates also
down-regulates CCR5.
To further address the effect of signal
duration on the induction of resistance, we compared beads-in
stimulation with continuous passage on anti-CD3/anti-CD28-coated plates
by using cells from two different donors. For these experiments,
noninfected enriched CD4 T cells were stimulated with
anti-CD3/anti-CD28 antibodies on beads (beads in) or on plastic dishes
where the cells were transferred to uncoated plates on day 3 or
passaged continuously on freshly coated plates. In the latter case,
plate-stimulated cells were harvested on day 3 poststimulation and
replated on fresh antibody-coated plates. This procedure was repeated
for each split of the culture. In these experiments, continuous passage on fresh anti-CD3/anti-CD28-coated plates resulted in prolonged down-regulation of CCR5 similar to that seen with continuous bead stimulation (Fig. 5A). Induction levels
of CD25 and CD69 expression were also analyzed. Both markers were
induced to a greater degree by bead stimulation than by plate
stimulation, as previously noted. Continuous passage on fresh
antibody-coated plates also had an effect on CD25 expression,
maintaining it at higher levels than those seen with one-time plate
stimulation, but still lower than those seen in the bead-stimulated
cultures. CD69 expression also was higher in bead-stimulated cultures
and was not dramatically affected by continuous plate stimulation (data
not shown).

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 5.
Effect of continuous plate stimulation on CCR5
expression and -chemokine production. (A) Noninfected CD4-enriched T
cells (60 to 85% CD4+) were stimulated as indicated and
stained for the expression of CCR5 at various times poststimulation as
described in the legend to Fig. 1. (B) Aliquots of culture supernatants
from the same CD4-enriched T cells were collected on days 3, 5, 7, 10, and 13 poststimulation and assayed for the presence of RANTES,
MIP-1 , MIP-1 , and IFN- by ELISA. The data in Fig. 5 is from
one of two donors yielding similar results.
|
|
Increased production of
-chemokines and IFN-
following
continuous plate stimulation.
In the same experiment, we also
asked whether continuous plate stimulation would increase production of
-chemokines and IFN-
similar to continuous bead stimulation. At
the indicated times postinfection, supernatants were assayed for the
presence of MIP-1
, MIP-1
, RANTES, and IFN-
by ELISA. Results
from one of two donors are shown in Fig. 5B. Bead-stimulated cells
produced relatively high levels of all four cytokines as expected. On
day 3 poststimulation, plate-stimulated cultures contained low levels
of all four cytokines. When the cells were transferred to uncoated
plates, there was little to no increase in cytokine production.
However, when the cells were repeatedly transferred to fresh
anti-CD3/anti-CD28-coated plates, the levels of all cytokines rose
continually over the next 10 days, reaching levels similar to those in
bead-stimulated cultures.
Continuous stimulation on anti-CD3/anti-CD28-coated plates
does not induce resistance to HIV infection.
Since
continuous plate stimulation caused the down-regulation of CCR5 and
increased secretion of
-chemokines, we expected that this method of
stimulation also would induce resistance to infection by M-tropic
strains of HIV-1. To test this hypothesis, enriched CD4 T cells were
infected with HIV-1 JRCSF and SF162 on day 3 and day 7 poststimulation
and the cultures were assayed for p24. Cells from two different donors
were tested with both viruses. The results are shown in Fig.
6. Continuous bead stimulation almost
completely inhibited virus replication, and one-time plate stimulation
led to high levels of p24 production, as observed in previous
experiments (Table 1; Fig. 2). Surprisingly, continuous plate
stimulation gave rise to high levels of p24 production relative to
those resulting from one-time plate stimulation, in most cases, and
sometimes higher. The lower levels of p24 production following infections on day 7 poststimulation are probably due to decreased cell
growth at this point in the cultures. The fact that neither one-time
nor continuous plate stimulation consistently leads to lower p24
production suggests that there is no real difference in these two
methods of stimulation in terms of resistance. To ensure that CCR5
expression was down-regulated during this experiment, we stained an
aliquot of cells from each culture for CCR5 on day 7 poststimulation.
The cells from the continuous plate-stimulated culture showed barely
detectable levels of CCR5 expression, as did bead-stimulated
cells (data not shown). In contrast, one-time plate-stimulated
cells had elevated levels of CCR5 expression, as observed in
previous experiments. Thus, continuous plate stimulation does not
protect CD4 T cells from HIV replication despite down-regulation of
CCR5 and production of
-chemokines. These results suggest that
down-regulation of CCR5 and production of
-chemokines may not be the
only factors that contribute to the induction of resistance by
anti-CD28 costimulation.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 6.
Resistance of T cells to infection following continuous
plate stimulation. Enriched primary CD4 T cells were stimulated with
anti-CD3/anti-CD28 antibodies immobilized on magnetic beads or on
plastic tissue culture plates and infected on either day 3 or day 7 poststimulation with HIV-1 JRCSF or SF162 at 50 ng of
p24/106 cells as described in Materials and Methods.
Supernatants were harvested on day 3 and day 7 postinfection and
analyzed for HIV-1 p24 by ELISA. Data from two different donors is
shown.
|
|
 |
DISCUSSION |
Many laboratories are currently using the combination of anti-CD3
plus anti-CD28 costimulation to recover infectious HIV from cells of
HIV-positive donors with low or undetectable viral loads. Yet
anti-CD3/anti-CD28 costimulation has also been reported to generate
resistance to infection by M-tropic strains of HIV-1 in vitro. In the
studies presented here, we have investigated the ability of anti-CD28
costimulation to induce resistance to HIV infection in vitro. Our
results show that the mode in which anti-CD28 and anti-CD3 are
coimmobilized and the duration of exposure to the stimulation determine
the generation of resistance and provide an explanation for the
apparently contradictory results regarding the effect of anti-CD28
costimulation on HIV replication in vitro. Our results with beads-in
and beads-out stimulation are consistent with those of Barker et al.
(2), who found that replication of M-tropic viruses was
blunted in the presence of CD3/CD28 beads but rebounded when the beads
were removed. In our hands, in cultures of T cells stimulated by
different methods of presentation of anti-CD3/anti-CD28 (beads-in,
beads-out, and one-time plate stimulation), resistance to infection
correlates with a decrease in surface expression of CCR5 coreceptor and
with production of the
-chemokines MIP-1
, MIP-1
, and RANTES.
Cultures which produce little p24 (high level of resistance) also have low to undetectable levels of CCR5 expression and produce the greatest
amounts of
-chemokines, and vice versa. Furthermore, CM from
beads-in cultures, which contains a high level of
-chemokines, augments resistance to HIV infection in beads-out and one-time plate-stimulated cultures. Thus, the mechanism of CD28-induced resistance appears to center around the availability of the CCR5 coreceptor.
One caveat of our surface staining experiments is that we did not start
with a pure population of CD4 T cells. Thus, observed changes in
surface expression of the various markers may reflect changes in cell
types other than CD4 T cells. However, we do not believe that this
factor has a significant effect on our results since the pattern of
surface marker expression was remarkably consistent from experiment to
experiment (donor to donor), and within a given experiment the same
starting cell population was used for every culture. Moreover, CCR5
expression in the entire cell population was uniformly affected by a
given treatment, indicating that all CD4 T cells in the population were
likewise uniformly affected.
If the apparent resistance to infection is due solely to the inhibition
of coreceptor usage, the effect of anti-CD3/anti-CD28 bead stimulation
is most likely to block subsequent rounds of infection rather than by
"curing" cells already infected. This hypothesis is supported by
the observations of Barker et al. (2) and Levine et al.
(15) that there is an initial burst of p24 production and
detection of gag DNA by PCR which disappears after the first
2 weeks of culture as the infected cells are eliminated. Furthermore,
the failure to develop resistance to T-tropic strains of HIV-1 might be
due to the inability to down-regulate or block the availability of the
T-tropic coreceptor CXCR4 (3, 10). This hypothesis also is
consistent with the findings of Levine et al. (15), who saw
no resistance to T-tropic strains of HIV-1 and found that CXCR4
expression was up-regulated by CD3/CD28 costimulation (5).
Stimulation by continuous passage on anti-CD3/CD28-coated plates
provides an exception to the above rule. In our hands, CD4 T cells
stimulated by continuous passage on anti-CD3/CD28-coated plates
produced high levels of p24 and therefore were not resistant to
infection despite down-regulated CCR5 expression and
increasing production of
-chemokines. At present, we have
no definitive explanation for this observation. No significant
difference in growth rate or behavior of the cells under the different
culture conditions was noted. One possibility is that the
down-regulation of CCR5 by plate stimulation is not as complete as
down-regulation by bead stimulation resulting in a low level of CCR5 on
the cell surface sufficient to propagate HIV infection in vitro.
Alternatively, factors other than the availability of CCR5 may play a
role in generating resistance to HIV infection. For example, other
coreceptors may be able to support infection by HIV-1 JRCSF and SF162
in plate-stimulated cells, or repeated stimulation by anti-CD3 and
anti-CD28 antibodies coimmobilized on the surface of a tissue culture
dish may increase the potential for infection by CCR5-independent mechanisms.
CD28 costimulation causes a bimodal down-regulation of CCR5 expression,
both decreasing the amount of CCR5 message (5) and reducing
surface expression (this report). With regard to surface expression, we
cannot rule out that the apparent down-regulation is due to inhibition
of staining by the presence of high levels of
-chemokines. However,
several lines of evidence suggest that the presence of
-chemokines
alone cannot account for the complete absence of CCR5 surface
expression among bead-stimulated T cells. First, the reduction in CCR5
mRNA levels induced by bead stimulation is consistent with a
concomitant decrease in surface expression; second, in one-time
plate-stimulated cultures, there is clearly an increase in CCR5
expression; third, CCR5 expression remains undetectable even when
chemokine levels are low or decreasing (early in plate-stimulated
cultures, late in beads-in cultures); and finally, other groups
studying the inhibition of infectivity by chemokines have observed only
a modest decrease in staining in the presence of chemokines
(26).
One issue raised by these studies is whether there is an
intrinsic difference between stimulation by
anti-CD3/anti-CD28 antibodies immobilized on beads and that on
the surface of a tissue culture plate, or if the effects are simply due
to the time of exposure to the stimulation. Clearly, both CCR5
expression and
-chemokine production are influenced by the time of
exposure to anti-CD3/CD28 beads. In cultures where the beads were not
removed, CCR5 expression remained undetectable throughout the culture
period and production of MIP-1
, MIP-1
, and RANTES remained
relatively high. When the beads were removed on day 3 poststimulation,
-chemokine production dropped off and CCR5 was slowly
reexpressed. These changes correlated with a breakdown in resistance to
HIV infection and resulted in significant levels of p24 production by
day 7 postinfection. Thus, the characteristics of the beads-out
cultures were similar to those of the one-time plate-stimulated
cultures, where the cells were removed from the antibody-coated plates
on day 3 poststimulation, but not entirely analogous. Bead-stimulated
cultures showed higher levels of
-chemokine production on day 3 than
plate-stimulated cultures despite continuous stimulation during that
time. Furthermore, although CCR5 expression was not significantly
different on day 3, one-time plate-stimulated cells expressed high
levels by day 5 to 7 poststimulation, whereas expression only slowly
increased after removal of beads on day 3 and did not reach the levels
in plate-stimulated cultures by day 13. Other differences between bead
and plate stimulation were observed by evaluating T-cell activation marker expression. Bead-stimulated cells expressed higher
levels of CD69 and CD25 on day 3 poststimulation. While CD69
expression dropped rapidly to baseline following removal of
beads, CD25 expression remained elevated significantly longer in
beads-out cultures than in one-time plate-stimulated cultures. The
latter observations suggest that there may be some intrinsic differences between bead and plate stimulation. The most striking evidence in support of such a difference is in the case of continuous plate stimulation, where resistance to infection does not correlate with CCR5 down-regulation and
-chemokine production. This is in
contrast to continuous bead stimulation (beads in), in which the cells
are resistant to infection. One possible explanation for these
differences is that the beads are able to bind and present more
antibody per unit area than the plate. We found no significant difference in the response of cells when we used five times the amount
of antibody (2.5 µg/ml) to coat the plates, either directly or
indirectly by first coating with goat anti-mouse IgG (data not shown).
This could be interpreted to suggest that increasing the ligand density
on the plates is not sufficient to overcome an intrinsic difference in
bead versus plate stimulation or simply that the ligand density on the
plate is still not equivalent to that displayed on the beads. More
direct measurement of the amount of antibody bound on the plate versus
that on the beads is required to resolve this issue. However, it would
still be difficult to rule out an effect of other factors such as
surface geometry.
CD28 has been postulated to have multiple signaling pathways associated
with it which can be delineated by using different cell culture systems
or different degrees of antibody cross-linking (12, 13, 22).
Differential signal strength and usage of B7-1 versus B7-2 have also
been reported to correlate with development of Th1 versus Th2 responses
in vitro and in vivo (14). Thus, the signals generated by
anti-CD3/anti-CD28 coimmobilized on beads and plates may result in
signals that are qualitatively or quantitatively different or both. The
fact that there are significant differences in the induction of T-cell
activation markers by plate and bead stimulation even when five times
the amount of coating antibody is used suggests that there may be
intrinsic biochemical differences in the signals generated by each of
these methods that are dictated by surface geometry. This hypothesis is
supported by the failure of plate stimulation to induce resistance to
HIV infection. Further investigation of these methods of
anti-CD3/anti-CD28 costimulation could provide insights into the
mechanism of CD28 signal transduction.
Finally, we have identified a method for inducing high levels of CCR5
coreceptor expression in vitro. Transient exposure (3 days) of CD4 T
cells to anti-CD3/anti-CD28 antibodies immobilized on the surface of a
tissue culture dish leads to the dramatic up-regulation of CCR5
expression once the cells are removed from the original stimulation.
This observation offers at least a partial explanation for the success
that has been achieved in using this method of stimulation to rescue
virus from the cells of AIDS patients with no dectable viral load as a
result of highly active antiretroviral therapy. Furthermore, we
demonstrate a method for dramatically reducing the level of CCR5
expression in vitro and maintaining expression at low to undectable
levels by using continuous anti-CD3/anti-CD28 stimulation by two means
which may have different outcomes in terms of virus replication. These
experimental systems may be useful for further studies of the role of
coreceptor usage in HIV infection.
 |
ACKNOWLEDGMENTS |
We thank Otto Yang and Bruce Walker, AIDS Research Center,
Massachusetts General Hospital and Harvard Medical School, Charlestown, Mass., for providing the M-tropic strains of HIV-1 and Gib Otten and
Carl June for helpful discussions and critical review of the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Present address: Becton Dickinson
Biosciences, 2350 Qume Dr., San Jose, CA 95131-1807. Phone: (408) 954-2354. Fax: (408) 954-2156. E-mail:
steve_anderson{at}bdis.com.
Present address: Departments of Microbiology and Internal Medicine,
Myles H. Thaler Center for AIDS and Human Retrovirus Research, University of Virginia, Charlottesville, VA 22908.
 |
REFERENCES |
| 1.
|
Alkhatib, G.,
C. Combadiere,
C. C. Broder,
Y. Feng,
P. E. Kennedy,
P. M. Murphy, and E. A. Berger.
1996.
CC CKR5: a RANTES, MIP-1 , MIP-1 receptor as a fusion cofactor for macrophage-tropic HIV-1.
Science
272:1955-1958[Abstract].
|
| 2.
|
Barker, E.,
K. N. Bossart, and J. A. Levy.
1998.
Differential effects of CD28 co-stimulation on HIV production by CD4+ T cells.
J. Immunol.
161:6223-6227[Abstract/Free Full Text].
|
| 3.
|
Bleul, C. C.,
L. Wu,
J. A. Hoxie,
T. A. Springer, and C. R. Mackay.
1997.
The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes.
Proc. Natl. Acad. Sci. USA
94:1925-1930[Abstract/Free Full Text].
|
| 4.
|
Cantrell, D. A., and K. A. Smith.
1984.
The interleukin-2 T cell system: a new cell growth model.
Science
224:1312-1316[Abstract/Free Full Text].
|
| 5.
|
Carroll, R. G.,
J. L. Riley,
B. L. Levine,
Y. Feng,
S. Kaushal,
D. W. Ritchey,
W. Bernstein,
O. S. Weislow,
C. R. Brown,
E. A. Berger,
C. H. June, and D. C. St. Louis.
1997.
Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells.
Science
276:273-276[Abstract/Free Full Text].
|
| 6.
|
Cocchi, F.,
A. L. DeVico,
A. Garzino-Demo,
S. K. Arya,
R. C. Gallo, and P. Lusso.
1995.
Identification of RANTES, MIP-1 , and MIP-1 as the major HIV-suppressive factors produced by CD8+ T cells.
Science
270:1811-1815[Abstract/Free Full Text].
|
| 7.
|
Connor, R. I.,
K. E. Sheridan,
D. Ceradini,
S. Choe, and N. R. Landau.
1997.
Change in coreceptor use correlates with disease progression in HIV-1 infected individuals.
J. Exp. Med.
185:621-628[Abstract/Free Full Text].
|
| 8.
|
Deng, H. K.,
R. Liu,
W. Ellmeier,
S. Choe,
D. Unutmaz,
M. Burkhart,
P. Di Marzio,
S. Marmon,
R. E. Sutton,
C. M. Hill,
C. B. Davis,
S. C. Peiper,
T. J. Schall,
D. R. Littman, and N. R. Landau.
1996.
Identification of a major co-receptor for primary isolates of HIV-1.
Nature
381:661-666[Medline].
|
| 9.
|
Dragic, T.,
V. Litwin,
G. P. Allaway,
S. R. Martin,
Y. Huang,
K. A. Nagashima,
C. Cayanan,
P. J. Maddon,
R. A. Koup,
J. P. Moore, and W. A. Paxton.
1996.
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.
Nature
381:667-673[Medline].
|
| 10.
|
Feng, Y.,
C. C. Broder,
P. E. Kennedy, and E. A. Berger.
1996.
HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane G protein-coupled receptor.
Science
272:872-877[Abstract].
|
| 11.
|
Greene, W. C., and W. J. Leonard.
1986.
The human interleukin 2 receptor.
Annu. Rev. Immunol.
4:69-96[Medline].
|
| 12.
|
June, C. H.,
J. A. Bluestone,
L. M. Nadler, and C. B. Thompson.
1994.
The B7 and CD28 receptor families.
Immunol. Today
15:321-331[Medline].
|
| 13.
|
Ledbetter, J. A.,
J. B. Imboden,
G. L. Schieven,
L. S. Grosmaire,
P. S. Rabinovitch,
T. Lindsten,
C. B. Thompson, and C. H. June.
1990.
CD28 ligation in T cell activation: evidence for two signal transduction pathways.
Blood
75:1531-1539[Abstract/Free Full Text].
|
| 14.
|
Lenschow, D. J.,
T. L. Walunas, and J. A. Bluestone.
1996.
CD28/B7 system of T cell costimulation.
Annu. Rev. Immunol.
14:233-258[Medline].
|
| 15.
|
Levine, B. L.,
J. D. Mosca,
J. L. Riley,
R. G. Carroll,
M. T. Vahey,
L. L. Jagodinski,
K. F. Wagner,
D. L. Mayers,
D. S. Burke,
O. S. Weislow,
D. C. St. Louis, and C. H. June.
1996.
Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation.
Science
272:1939-1943[Abstract].
|
| 16.
|
Levine, B. L.,
W. B. Bernstein,
M. Connors,
N. Craighead,
T. Lindsten,
C. B. Thompson, and C. H. June.
1997.
Effects of CD28 co-stimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells.
J. Immunol.
159:5921-5930[Abstract].
|
| 17.
|
Levine, B. L.,
Y. Ueda,
N. Craighead,
M. L. Huang, and C. H. June.
1995.
CD28 ligands CD80 (B7-1) and CD86 (B7-2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokine production in vitro.
Int. Immunol.
7:891-904[Abstract/Free Full Text].
|
| 18.
|
Liu, R.,
W. A. Paxton,
S. Choe,
D. Ceradini,
S. R. Martin,
R. Horuk,
M. E. MacDonald,
H. Stuhlmann,
R. A. Koup, and N. R. Landau.
1996.
Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection.
Cell
86:367-377[Medline].
|
| 19.
|
Paxton, W. A.,
S. R. Martin,
D. Tse,
T. R. O'Brien,
J. Skurnick,
N. L. VanDeventer,
N. Padian,
J. F. Braun,
D. P. Kotler,
S. M. Wolinsky, and R. A. Koup.
1996.
Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures.
Nat. Med.
2:412-417[Medline].
|
| 20.
|
Riley, J. L.,
R. G. Carroll,
B. L. Levine,
W. Bernstein,
D. C. St. Louis,
O. S. Weislow, and C. H. June.
1997.
Intrinsic resistance to T cell infection with HIV type 1 induced by CD28 costimulation.
J. Immunol.
158:5545-5553[Abstract].
|
| 21.
|
Roederer, M.,
P. A. Raju,
D. K. Mitra,
L. A. Herzenberg, and L. A. Herzenberg.
1997.
HIV does not replicate in naïve CD4 T cells stimulated with CD3/CD28.
J. Clin. Invest.
99:1555-1564[Medline].
|
| 22.
|
Rudd, C.
1996.
Upstream-downstream: CD28 cosignaling pathways and T cell function.
Immunity
4:527-534[Medline].
|
| 23.
|
Simmons, G.,
P. R. Clapham,
L. Picard,
R. E. Offord,
M. M. Rosenkilde,
T. W. Schwartz,
R. Buser,
T. N. C. Wells, and A. E. I. Proudfoot.
1997.
Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.
Science
276:276-279[Abstract/Free Full Text].
|
| 24.
|
Spina, C. A.,
H. E. Prince, and D. D. Richman.
1997.
Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro.
J. Clin. Invest.
99:1774-1785[Medline].
|
| 25.
|
Testi, R.,
J. H. Philips, and L. L. Lanier.
1989.
Leu-23 induction as an early activation marker for functional CD3/T cell antigen receptor triggering: requirement for receptor cross-linking, prolonged elevation of intracellular Ca++, and stimulation of protein kinase C.
J. Immunol.
142:1854-1860[Abstract].
|
| 26.
|
Trkola, A.,
W. A. Paxton,
S. P. Monard,
J. A. Hoxie,
M. A. Siani,
D. A. Thompson,
L. Wu,
C. R. Mackay,
R. Horuk, and J. P. Moore.
1998.
Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines.
J. Virol.
72:396-404[Abstract/Free Full Text].
|
| 27.
|
Wong, J. K.,
M. Hezareth,
H. F. Gunthard,
D. V. Havlir,
C. C. Ignacio,
C. A. Spina, and D. D. Richman.
1997.
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.
Science
278:1291-1295[Abstract/Free Full Text].
|
| 28.
|
Wu, L.,
W. A. Paxton,
N. Kassam,
N. Ruffing,
J. B. Rottman,
N. Sullivan,
H. Choe,
J. Sodroski,
W. Newman,
R. A. Koup, and C. R. Mackay.
1997.
CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro.
J. Exp. Med.
185:1681-1691[Abstract/Free Full Text].
|
Journal of Virology, November 1999, p. 9337-9347, Vol. 73, No. 11
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Mummidi, S., Adams, L. M., VanCompernolle, S. E., Kalkonde, M., Camargo, J. F., Kulkarni, H., Bellinger, A. S., Bonello, G., Tagoh, H., Ahuja, S. S., Unutmaz, D., Ahuja, S. K.
(2007). Production of Specific mRNA Transcripts, Usage of an Alternate Promoter, and Octamer-Binding Transcription Factors Influence the Surface Expression Levels of the HIV Coreceptor CCR5 on Primary T Cells. J. Immunol.
178: 5668-5681
[Abstract]
[Full Text]
-
Schweighardt, B., Roy, A.-M., Meiklejohn, D. A., Grace, E. J. II, Moretto, W. J., Heymann, J. J., Nixon, D. F.
(2004). R5 Human Immunodeficiency Virus Type 1 (HIV-1) Replicates More Efficiently in Primary CD4+ T-Cell Cultures Than X4 HIV-1. J. Virol.
78: 9164-9173
[Abstract]
[Full Text]
-
Zloza, A., Sullivan, Y. B., Connick, E., Landay, A. L., Al-Harthi, L.
(2003). CD8+ T cells that express CD4 on their surface (CD4dimCD8bright T cells) recognize an antigen-specific target, are detected in vivo, and can be productively infected by T-tropic HIV. Blood
102: 2156-2164
[Abstract]
[Full Text]
-
Mo, R., Chen, J., Han, Y., Bueno-Cannizares, C., Misek, D. E., Lescure, P. A., Hanash, S., Yung, R. L.
(2003). T Cell Chemokine Receptor Expression in Aging. J. Immunol.
170: 895-904
[Abstract]
[Full Text]
-
Cook, J. A., August, A., Henderson, A. J.
(2002). Recruitment of Phosphatidylinositol 3-Kinase to CD28 Inhibits HIV Transcription by a Tat-Dependent Mechanism. J. Immunol.
169: 254-260
[Abstract]
[Full Text]
-
McNeil, A. C., Shupert, W. L., Iyasere, C. A., Hallahan, C. W., Mican, J., Davey, R. T. Jr., Connors, M.
(2001). High-level HIV-1 viremia suppresses viral antigen-specific CD4+ T cell proliferation. Proc. Natl. Acad. Sci. USA
98: 13878-13883
[Abstract]
[Full Text]
-
Mengozzi, M., Malipatlolla, M., De Rosa, S. C., Herzenberg, L. A., Herzenberg, L. A., Roederer, M.
(2001). Naive CD4 T cells inhibit CD28-costimulated R5 HIV replication in memory CD4 T cells. Proc. Natl. Acad. Sci. USA
10.1073/pnas.211205098v1
[Abstract]
[Full Text]
-
Mengozzi, M., Malipatlolla, M., De Rosa, S. C., Herzenberg, L. A., Herzenberg, L. A., Roederer, M.
(2001). Naive CD4 T cells inhibit CD28-costimulated R5 HIV replication in memory CD4 T cells. Proc. Natl. Acad. Sci. USA
98: 11644-11649
[Abstract]
[Full Text]